161 related articles for article (PubMed ID: 27765729)
1. Infection With Hepatitis C Virus Genotype 3 Is an Independent Risk Factor for End-Stage Liver Disease, Hepatocellular Carcinoma, and Liver-Related Death.
McMahon BJ; Bruden D; Townshend-Bulson L; Simons B; Spradling P; Livingston S; Gove J; Hewitt A; Plotnik J; Homan C; Espera H; Negus S; Snowball M; Barbour Y; Bruce M; Gounder P
Clin Gastroenterol Hepatol; 2017 Mar; 15(3):431-437.e2. PubMed ID: 27765729
[TBL] [Abstract][Full Text] [Related]
2. Adverse outcomes in Alaska natives who recovered from or have chronic hepatitis C infection.
McMahon BJ; Bruden D; Bruce MG; Livingston S; Christensen C; Homan C; Hennessy TW; Williams J; Sullivan D; Rosen HR; Gretch D
Gastroenterology; 2010 Mar; 138(3):922-31.e1. PubMed ID: 19909749
[TBL] [Abstract][Full Text] [Related]
3. Risk of end-stage liver disease, hepatocellular carcinoma, and liver-related death by fibrosis stage in the hepatitis C Alaska Cohort.
Bruden DJT; McMahon BJ; Townshend-Bulson L; Gounder P; Gove J; Plotnik J; Homan C; Hewitt A; Barbour Y; Spradling PR; Simons BC; McArdle S; Bruce M
Hepatology; 2017 Jul; 66(1):37-45. PubMed ID: 28195349
[TBL] [Abstract][Full Text] [Related]
4. Short-Term Incidence of Sequelae of HCV Infection Among Medicaid Beneficiaries in Oregon.
Jindai K; Crawford C; Thomas AR
Public Health Rep; 2019; 134(1):81-88. PubMed ID: 30508493
[TBL] [Abstract][Full Text] [Related]
5. Data linkage to monitor hepatitis C-associated end-stage liver disease and hepatocellular carcinoma inpatient stays in England.
Ireland G; Simmons R; Hickman M; Harris R; Ramsay M; Sabin C; Mandal S
J Viral Hepat; 2020 Jan; 27(1):20-27. PubMed ID: 31505083
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus genotype 3 was associated with the development of hepatocellular carcinoma in Korea.
Lee SS; Kim CY; Kim BR; Cha RR; Kim WS; Kim JJ; Lee JM; Kim HJ; Ha CY; Kim HJ; Kim TH; Jung WT; Lee OJ
J Viral Hepat; 2019 Apr; 26(4):459-465. PubMed ID: 30516858
[TBL] [Abstract][Full Text] [Related]
7. Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients.
Lo Re V; Newcomb CW; Carbonari DM; Roy JA; Althoff KN; Kitahata MM; Reddy KR; Lim JK; Silverberg MJ; Mayor AM; Horberg MA; Cachay ER; Kirk GD; Hull M; Gill J; Sterling TR; Kostman JR; Peters MG; Moore RD; Klein MB; Kim HN;
J Acquir Immune Defic Syndr; 2019 Sep; 82(1):71-80. PubMed ID: 31107304
[TBL] [Abstract][Full Text] [Related]
8. Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected Patients.
Salmon-Ceron D; Nahon P; Layese R; Bourcier V; Sogni P; Bani-Sadr F; Audureau E; Merchadou L; Dabis F; Wittkop L; Roudot-Thoraval F;
Hepatology; 2019 Sep; 70(3):939-954. PubMed ID: 30569448
[TBL] [Abstract][Full Text] [Related]
9. Mortality among Alaska Native Adults with Confirmed Hepatitis C Virus Infection Compared with the General Population in Alaska, 1995-2016.
Bressler SS; Bruden D; Nolen LD; Bruce MG; Towshend-Bulson L; Spradling P; McMahon BJ
Can J Gastroenterol Hepatol; 2022; 2022():2573545. PubMed ID: 35178364
[TBL] [Abstract][Full Text] [Related]
10. Epidemic spread of hepatitis C virus genotype 3a and relation to high incidence of hepatocellular carcinoma in Pakistan.
Khan A; Tanaka Y; Azam Z; Abbas Z; Kurbanov F; Saleem U; Hamid S; Jafri W; Mizokami M
J Med Virol; 2009 Jul; 81(7):1189-97. PubMed ID: 19475617
[TBL] [Abstract][Full Text] [Related]
11. The natural history of hepatitis C virus infection: host, viral, and environmental factors.
Thomas DL; Astemborski J; Rai RM; Anania FA; Schaeffer M; Galai N; Nolt K; Nelson KE; Strathdee SA; Johnson L; Laeyendecker O; Boitnott J; Wilson LE; Vlahov D
JAMA; 2000 Jul; 284(4):450-6. PubMed ID: 10904508
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of hepatitis C infection in a large cohort of patients with inherited bleeding disorders.
Fransen van de Putte DE; Makris M; Fischer K; Yee TT; Kirk L; van Erpecum KJ; Patch D; Posthouwer D; Mauser-Bunschoten EP
J Hepatol; 2014 Jan; 60(1):39-45. PubMed ID: 23978717
[TBL] [Abstract][Full Text] [Related]
13. HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis.
Nkontchou G; Ziol M; Aout M; Lhabadie M; Baazia Y; Mahmoudi A; Roulot D; Ganne-Carrie N; Grando-Lemaire V; Trinchet JC; Gordien E; Vicaut E; Baghad I; Beaugrand M
J Viral Hepat; 2011 Oct; 18(10):e516-22. PubMed ID: 21914071
[TBL] [Abstract][Full Text] [Related]
14. The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias?
Goodgame B; Shaheen NJ; Galanko J; El-Serag HB
Am J Gastroenterol; 2003 Nov; 98(11):2535-42. PubMed ID: 14638360
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus load and survival among injection drug users in the United States.
Hisada M; Chatterjee N; Kalaylioglu Z; Battjes RJ; Goedert JJ
Hepatology; 2005 Dec; 42(6):1446-52. PubMed ID: 16317675
[TBL] [Abstract][Full Text] [Related]
16. Chronic hepatitis c genotype-4 infection: role of insulin resistance in hepatocellular carcinoma.
Mohamed AA; Loutfy SA; Craik JD; Hashem AG; Siam I
Virol J; 2011 Nov; 8():496. PubMed ID: 22044490
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study.
Lee MH; Yang HI; Lu SN; Jen CL; Yeh SH; Liu CJ; Chen PJ; You SL; Wang LY; Chen WJ; Chen CJ
J Clin Oncol; 2010 Oct; 28(30):4587-93. PubMed ID: 20855826
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma.
Lee MH; Yang HI; Lu SN; Jen CL; You SL; Wang LY; L'Italien G; Chen CJ; Yuan Y;
Int J Cancer; 2014 Sep; 135(5):1119-26. PubMed ID: 24482200
[TBL] [Abstract][Full Text] [Related]
19. Incidence of hepatocellular carcinoma according to hepatitis B virus genotype in Alaska Native people.
Ching LK; Gounder PP; Bulkow L; Spradling PR; Bruce MG; Negus S; Snowball M; McMahon BJ
Liver Int; 2016 Oct; 36(10):1507-15. PubMed ID: 27009849
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma, decompensation, and mortality based on hepatitis C treatment: A prospective cohort study.
Choi GH; Jang ES; Kim YS; Lee YJ; Kim IH; Cho SB; Lee HC; Jang JW; Ki M; Choi HY; Baik D; Jeong SH
World J Gastroenterol; 2022 Aug; 28(30):4182-4200. PubMed ID: 36157119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
